Source link : https://www.newshealth.biz/health-news/arrhythmia-risk-of-lamotrigine-questioned-by-observational-data/
LOS ANGELES — The FDA’s warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn’t borne out in observational cohorts of people with epilepsy, although the risk did appear significant in people with bipolar disease. The difference in findings presented at the American Epilepsy Society (AES) annual meeting appeared to be due […]
Author : News Health
Publish date : 2024-12-10 18:05:36
Copyright for syndicated content belongs to the linked Source.